Company intelligence / Profile preview

Neurologix

Fort Lee, New Jersey, United Statesneurologixtech.com ↗

Ownership: Private
Development stage: Other

Overview

Neurologix completed all surgical procedures in a clinical trial targeting advanced Parkinson’s disease using gene therapy. The company was among the early pioneers developing gene transfer therapies for serious brain and CNS disorders. No recent clinical results are available due to the company being out of business since the early 2010s.

Therapeutic areas: Neurology
Modalities: Gene therapy
Industry: Biotech

Drug pipeline

1 asset

AAVNPY

Unknown

Partnerships

No major pharmaceutical or biotech partnerships reported in public sources.

Beyond the preview

Go deeper on Neurologix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurologix.

Explore the full profile